查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434513

痤瘡治療藥物市場：按痤瘡類型、藥物類別、藥物類型、給藥途徑- 全球預測 2024-2030

Acne Drugs Market by Acne Type (Comedonal, Cystic, Inflammatory), Drug Class (Antibiotics, Combination Drugs, Hormonal Agents), Drug Type, Route of Administration - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年痤瘡治療市場規模為59.6億美元，預計2024年將達到63.2億美元，2030年將達到91億美元，複合年成長率為6.23%。

全球痤瘡治療藥物市場

主要市場統計
基準年[2023] 59.6億美元
預測年份 [2024] 63.2億美元
預測年份 [2030] 91億美元
複合年成長率（%） 6.23%
痤瘡治療藥物市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估痤瘡治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對痤瘡治療藥物市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-痤瘡治療藥物市場的市場規模和預測是多少？

2-在痤瘡治療藥物市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-痤瘡治療藥物市場的技術趨勢和法律規範是什麼？

4-痤瘡治療藥物市場主要供應商的市場佔有率是多少？

5-進入痤瘡治療市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球皮膚相關疾病的發生率增加
      • 皮膚健康意識不斷增強，個人化、個人化治療趨勢不斷增強
      • 提高電子商務平台上痤瘡治療的可用性
    • 抑制因素
      • 有多種護膚藥物替代品
    • 機會
      • 改進和增強痤瘡治療簡介
      • 聯合治療的新需求
    • 任務
      • 化妝品核准法規嚴格、流程複雜
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章按痤瘡類型分類的痤瘡治療藥物市場

  • 粉刺
  • 囊狀的
  • 發炎的
  • 手術後/傷口

第7章按藥物類別分類的痤瘡治療藥物市場

  • 抗生素
  • 組合藥物
  • 荷爾蒙藥物
  • 類視色素A

第8章按藥物類型分類的痤瘡治療藥物市場

  • 非處方藥物
  • 處方藥

第9章痤瘡治療藥物市場：依給藥途徑

  • 可注射的
  • 口服
  • 話題

第10章美洲痤瘡治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區痤瘡治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章：歐洲、中東和非洲的痤瘡治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • AbbVie Inc.
    • Almirall, SA
    • Amgen, Inc.
    • Apotex Inc.
    • Arctic Therapeutics
    • Bausch Health Companies Inc.
    • Bayer AG
    • BioPharmX, Inc.
    • Cipher Pharmaceuticals Inc.
    • Daiichi Sankyo Company, Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • F. Hoffmann-La Roche AG
    • Galderma SA
    • Intas Pharmaceuticals Ltd.
    • Johnson & Johnson Services, Inc.
    • Mayne Pharma Group Limited
    • Midas Pharma GmbH
    • Mylan NV
    • Novartis AG
    • Pfizer Inc.
    • Skinvisible Pharmaceuticals, Inc.
    • Stiefel Laboratories, Inc. by GSK Group
    • Sun Pharmaceutical Industries Limited
    • Teva Pharmaceutical Industries Ltd.
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-434CCDA051B6

[192 Pages Report] The Acne Drugs Market size was estimated at USD 5.96 billion in 2023 and expected to reach USD 6.32 billion in 2024, at a CAGR 6.23% to reach USD 9.10 billion by 2030.

Global Acne Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 5.96 billion
Estimated Year [2024] USD 6.32 billion
Forecast Year [2030] USD 9.10 billion
CAGR (%) 6.23%
Acne Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Acne Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Acne Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Acne Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almirall, S.A., Amgen, Inc., Apotex Inc., Arctic Therapeutics, Bausch Health Companies Inc., Bayer AG, BioPharmX, Inc., Cipher Pharmaceuticals Inc., Daiichi Sankyo Company, Ltd., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche AG, Galderma S.A., Intas Pharmaceuticals Ltd., Johnson & Johnson Services, Inc., Mayne Pharma Group Limited, Midas Pharma GmbH, Mylan N.V, Novartis AG, Pfizer Inc., Skinvisible Pharmaceuticals, Inc., Stiefel Laboratories, Inc. by GSK Group, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Acne Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Acne Type
    • Comedonal
    • Cystic
    • Inflammatory
    • Postsurgical/Wound
  • Drug Class
    • Antibiotics
    • Combination Drugs
    • Hormonal Agents
    • Retinoids
  • Drug Type
    • OTC Drugs
    • Prescription Drugs
  • Route of Administration
    • Injectable
    • Oral
    • Topical
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Acne Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Acne Drugs Market?

3. What are the technology trends and regulatory frameworks in the Acne Drugs Market?

4. What is the market share of the leading vendors in the Acne Drugs Market?

5. Which modes and strategic moves are suitable for entering the Acne Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Acne Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of skin-related diseases in individuals worldwide
      • 5.1.1.2. Growing awareness regarding skin health and inclination toward specific personalized treatments
      • 5.1.1.3. Increasing availability of acne drugs on eCommerce platforms
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of numerous alternatives for skin care drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of improved and enhanced acne drugs
      • 5.1.3.2. Emerging demand for combination therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and complicated processes in the approval of cosmetic drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Acne Drugs Market, by Acne Type

  • 6.1. Introduction
  • 6.2. Comedonal
  • 6.3. Cystic
  • 6.4. Inflammatory
  • 6.5. Postsurgical/Wound

7. Acne Drugs Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Combination Drugs
  • 7.4. Hormonal Agents
  • 7.5. Retinoids

8. Acne Drugs Market, by Drug Type

  • 8.1. Introduction
  • 8.2. OTC Drugs
  • 8.3. Prescription Drugs

9. Acne Drugs Market, by Route of Administration

  • 9.1. Introduction
  • 9.2. Injectable
  • 9.3. Oral
  • 9.4. Topical

10. Americas Acne Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Acne Drugs Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Acne Drugs Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. AbbVie Inc.
    • 14.1.2. Almirall, S.A.
    • 14.1.3. Amgen, Inc.
    • 14.1.4. Apotex Inc.
    • 14.1.5. Arctic Therapeutics
    • 14.1.6. Bausch Health Companies Inc.
    • 14.1.7. Bayer AG
    • 14.1.8. BioPharmX, Inc.
    • 14.1.9. Cipher Pharmaceuticals Inc.
    • 14.1.10. Daiichi Sankyo Company, Ltd.
    • 14.1.11. Dr. Reddy's Laboratories Ltd.
    • 14.1.12. F. Hoffmann-La Roche AG
    • 14.1.13. Galderma S.A.
    • 14.1.14. Intas Pharmaceuticals Ltd.
    • 14.1.15. Johnson & Johnson Services, Inc.
    • 14.1.16. Mayne Pharma Group Limited
    • 14.1.17. Midas Pharma GmbH
    • 14.1.18. Mylan N.V
    • 14.1.19. Novartis AG
    • 14.1.20. Pfizer Inc.
    • 14.1.21. Skinvisible Pharmaceuticals, Inc.
    • 14.1.22. Stiefel Laboratories, Inc. by GSK Group
    • 14.1.23. Sun Pharmaceutical Industries Limited
    • 14.1.24. Teva Pharmaceutical Industries Ltd.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ACNE DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ACNE DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ACNE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ACNE DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ACNE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ACNE DRUGS MARKET DYNAMICS
  • FIGURE 7. ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 10. ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 12. ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 14. ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ACNE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ACNE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ACNE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ACNE DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ACNE DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ACNE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACNE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ACNE DRUGS MARKET SIZE, BY COMEDONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ACNE DRUGS MARKET SIZE, BY CYSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ACNE DRUGS MARKET SIZE, BY INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ACNE DRUGS MARKET SIZE, BY POSTSURGICAL/WOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 11. ACNE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ACNE DRUGS MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ACNE DRUGS MARKET SIZE, BY HORMONAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ACNE DRUGS MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. ACNE DRUGS MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ACNE DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 19. ACNE DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ACNE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ACNE DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ACNE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. ACNE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 191. ACNE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. ACNE DRUGS MARKET LICENSE & PRICING